Improvement of recalcitrant Hailey-Hailey disease (&lt;i&gt;ATP2C1&lt;/i&gt;-nonsyndromic epidermal differentiation disorder) with topical ruxolitinib 1.5% cream. Here, ATP2C1 is linked to Hailey-Hailey disease.